Landmark accelerator program launched at Burnet Institute
Changes to Burnet's board
NHMRC grant supports development for new malaria vaccines
Dorabjee Award recipient empowers change and honours a legacy
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Dynamic nucleolar targeting of dengue virus polymerase NS5 in response to extrac...
PRECISE pregnancy cohort: challenges and strategies in setting up a biorepositor...
Harnessing the PRECISE network as a platform to strengthen global capacity for m...
Strengthening midwifery in response to global climate change to protect maternal...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Current Appeal
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Head: Professor Mark Hogarth. Creating powerful antibody-based biological drugs which will...
